导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -29.83% | 4735/4773 |
| 近一周 | -0.65% | 1685/5467 |
| 近一月 | -5.03% | 2108/5421 |
| 近一季 | -10.98% | 3413/5238 |
| 近半年 | -27.79% | 4880/4931 |
| 近一年 | -34.46% | 4311/4400 |
| 近两年 | -3.91% | 2923/2954 |
| 近三年 | 0.70% | 1907/2253 |
| 成立以来 | 72.72% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-5.57% 3877/4961 |
-22.66% 4922/5312 |
- - |
- - |
| 2025 | 2.10% 3202/4813 |
-0.10% 2056/3635 |
-2.69% 3370/4076 |
12.56% 3064/4524 |
-6.69% 3728/4813 |
| 2024 | 35.61% 54/3463 |
7.02% 267/2808 |
0.93% 524/3014 |
13.94% 2073/3129 |
10.19% 284/3463 |
| 2023 | 7.61% 139/2656 |
2.23% 1401/2280 |
0.35% 325/2385 |
2.21% 246/2515 |
2.62% 62/2655 |
| 2022 | -20.24% 948/2207 |
-21.78% 1652/1919 |
34.27% 1/2016 |
-21.40% 1902/2113 |
-3.38% 1848/2208 |
| 2021 | 10.86% 414/1822 |
-14.91% 1183/1255 |
30.57% 37/1330 |
0.10% 469/1466 |
-0.32% 1223/1822 |
| 2020 | 78.89% 44/1250 |
-0.72% 191/1028 |
3.58% 936/1067 |
28.07% 17/1164 |
35.84% 13/1184 |
| 2019 | 11.84% 723/1092 |
18.07% 650/739 |
-4.92% 442/788 |
-3.16% 729/850 |
2.87% 854/918 |
| 2018 | -32.82% 540/834 |
- - |
-12.35% 389/631 |
-6.98% 424/660 |
-11.20% 262/682 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 港股医疗ETF | 1.4546 | 31.90% |
| 华富中证港股通创新药指数型发起式A | 1.1637 | 30.96% |
| 天弘恒生沪深港创新药精选50ETF发起联接A | 1.3128 | 30.52% |
| 中欧中证港股通创新药指数发起A | 1.6103 | 30.52% |
| 嘉实中证港股通创新药指数发起式C | 0.8566 | 30.50% |
| 中欧中证港股通创新药指数发起C | 1.4583 | 30.44% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8927 | 30.26% |
| 景顺长城中证港股通创新药ETF联接C | 1.4696 | 29.97% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8736 | 29.94% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8719 | 29.88% |
| 广发中证全指汽车指数A VS. 长安沪深300非周期A(740101) |